Krishna Institute of Medical Sciences Limited (NSE:KIMS)

NSE:KIMS Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	39,046	39,046	30,351	24,982	21,977	16,508
Revenue Growth	28.65%	28.65%	21.49%	13.68%	33.13%	24.13%
Gross Profit Gross Profit Growth	23,131	23,131	18,223	14,822	13,184	9,832
Operating Income Operating Income Growth	5,209	5,209	6,064	4,912	4,755	4,471
Net Income Net Income Growth	2,414	2,414	3,845	3,100	3,363	3,327
Earnings Per Share EPS Growth	6.03	6.03	9.61	7.75	8.41	8.38
EPS Growth	-37.25%	-37.25%	24.03%	-7.83%	0.35%	58.51%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	705	705	780	1,319	1,343	1,900
Total Debt Total Debt Growth	42,529	42,529	25,616	13,555	6,782	2,565
Net Cash (Debt) Net Cash Growth	-41,824	-41,824	-24,836	-12,236	-5,439	-665.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-104.52	-104.52	-62.07	-30.58	-13.59	-1.68

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	5,108	5,108	5,818	5,212	4,321	3,240
Capital Expenditures CapEx Growth	-14,279	-14,279	-10,089	-6,473	-5,745	-1,703
Free Cash Flow Free Cash Flow Growth	-9,171	-9,171	-4,271	-1,261	-1,424	1,537
Free Cash Flow Growth	-	-	-	-	-	-41.23%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	59.24%	59.24%	60.04%	59.33%	59.99%	59.56%
Operating Margin	13.34%	13.34%	19.98%	19.66%	21.63%	27.09%
Pretax Margin	8.55%	8.55%	18.39%	18.39%	22.06%	27.67%
Profit Margin	6.18%	6.18%	12.67%	12.41%	15.30%	20.15%
FCF Margin	-23.49%	-23.49%	-14.07%	-5.05%	-6.48%	9.31%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	133.45	103.02	66.56	53.16	33.35	33.27
Forward PE	76.03	63.26	57.37	43.29	30.55	30.33
P/FCF Ratio	-	-	-	-	-	72.02
PS Ratio	8.25	6.37	8.43	6.60	5.10	6.71

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error